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A Common Variant in SLC8A1 Is Associated with
the Duration of the Electrocardiographic QT Interval
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Yoshikuni Kita,4 Takeshi Tanigawa,5 Yoon Shin Cho,1,6 Bok-Ghee Han,1,* and Bermseok Oh7,*
Prolongation of the electrocardiographic QT interval, a measure of cardiac repolarization, predisposes one to ventricular arrhythmias
and sudden cardiac death. Since NOS1AP, a regulator of neuronal nitric oxide synthase, was discovered in a genome-wide association
study (GWAS) as a novel target that modulates cardiac repolarization, several loci have been linked to the QT interval in studies (QTGEN
and QTSCD) of European descendents. However, there has been no GWAS of the QT interval in Asian populations. We conducted
a GWAS with regard to the QT interval in Korea Association Resource (KARE [n ¼ 6,805]) cohorts. Replication studies in independent
populations of Korean (n ¼ 4,686) and Japanese (n ¼ 2,687) groups validated the association between a SNP, rs13017846, which
maps to near SLC8A1 (sodium/calcium exchanger 1 precursor, overall p ¼ 8.03 1014), and the QT interval. The minor allele frequency
(MAF) of rs13017846 varies widely between ethnicities—0.053 in Europeans (HapMapCEU [Utah residents with ancestry from northern
and western Europe from the Centre d0E´tude du Polymorphisme Humain collection] samples) versus 0.080 in Africans (HapMap YRI
[Yoruba in Ibadan, Nigeria] samples)—whereas a MAF of 0.500 has been reported in Asians (HapMap HCB [Han Chinese in Beijing,
China] and JPT [Japanese in Tokyo, Japan] samples). This might explain why this locus has not been identified in Europeans in previous
studies.Sudden cardiac death by acute ventricular arrhythmia is
a common cause of mortality in developed countries.1,2
Prolongation of ventricular repolarization increases the
risk of ventricular arrhythmia, as observed in congenital
long QT syndrome (LQTS), a rare Mendelian disorder.3
The QT interval—the span between the start of the Q
wave and the end of the T wave of the cardiac electrical
cycle—is the traditional measure of the duration of ventric-
ular depolarization and repolarization4 and is genetically
influenced (it has approximately 50% heritability).5,6
Since NOS1AP (MIM 610141), a regulator of neuronal ni-
tric oxide synthase, was identified in a genome-wide asso-
ciation study (GWAS) as a novel target that modulates
cardiac repolarization,7 several loci have been linked to
the QT interval in studies (QTGEN and QTSCD) of Euro-
pean descendents.8,9 However, no GWAS on the QT
interval has been performed on Asian populations.
To understand the genetic architecture of QT intervals
in Asians, we conducted a GWAS by using data from
Korea Association Resource (KARE [phase 1, n ¼ 6,805])10
during the discovery phase and two subsequent replication
studies (phase 2) in independent Korean (n ¼ 4,686) and
Japanese (n ¼ 2,687) populations. The studies from
which this report collected data acquired informed
consent from all participants and were approved by the
appropriate ethics committees at the respective institu-
tions and countries.1Center for Genome Science, National Institutes of Health, Korea Centers fo
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180 The American Journal of Human Genetics 91, 180–184, July 13, 2The overall study design is shown in Figure S1, available
online. Of the 8,842 original KARE discovery-phase partic-
ipants, those who had missing electrocardiographic
data were excluded (n ¼ 1,713). Also, participants with
a history of ischemic heart disease, stroke, coronary-artery
bypass surgery, or electrocardiographic findings, such as
atrial fibrillation, QRS duration > 120 ms, right or left
bundle-branch block, and frequent ventricular premature
beats >10% of the beats, were excluded (n ¼ 324). Partici-
pants with electrocardiogram (ECG) abnormalities, as
defined by the presence of Minnesota codes 1.1, 1.2 (major
Q wave), 4 or 5 (ST and T wave changes), 7.1–7.6 (ventric-
ular-conduction defect), or 8.1 (frequent atrial or ventric-
ular premature contraction) to 8.3 (atrial fibrillation or
flutter),11 were excluded from the analysis. We also
excluded subjects who were being treated with medica-
tions that were likely to modify the duration of the QT
interval (n ¼ 34).4
The final number of subjects for the GWAS was 6,805.
The same exclusion criteria were applied for the phase 2
replication studies, although the population characteris-
tics and genotyping platforms varied between studies
(Tables S1 and S2 and Figure S2).
To measure QT intervals in the phase 1 study, we ob-
tained a supine 12-lead ECG by using a MAC 5000 (GE
Medical System, CT, USA). On the basis of the 12-lead
ECG, the QT interval was measured from the earliest onsetr Disease Control and Prevention, Osong 363-951, Korea; 2Department of
e, Seoul 138-736, Korea; 3Department of Basic Medical Research and Educa-
4Department of Health Science, Shiga University of Medical Science, Otsu
School of Medicine, Toon 791-0295, Japan; 6Department of Biomedical
omedical Engineering, School of Medicine, Kyung Hee University, Seoul
Genetics. All rights reserved.
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Table 1. Previously Reported Loci Showing Associations with QTc Interval in the Phase 1 GWAS
Gene
GWAS
SNP
Effect
Size (b)
in ms
95% Confidence
Interval
GWAS p
Reported
SNP
Effect
Size (b)
in ms
95% Confidence
Interval
Reported
p
Study
Popu-
lation
Distance
from
GWAS
SNP (bp)
LD States
Lower Upper Lower Upper r2 D0
NOS1AP rs4657175 1.709 1.156 2.261 1.4 3 109 rs4657178 2.19 1.76 2.62 7 3 1033 QTSCD 14,873 0.53 0.97
NDRG4-
CNOT1
rs37060 1.52 0.957 2.084 1.3 3 107 rs37060 1.75 1.41 2.09 3 3 1025 QTGEN 0 1 1
KCNQ1 rs16928297 1.105 0.5582 1.653 7.6 3 105 rs12296050 1.49 0.95 1.93 3 3 1017 QTSCD 3,222 0.91 1
PLN rs7764093 0.869 0.2894 1.449 0.00331 rs11970286 1.64 1.25 2.03 2 3 1024 QTSCD 11,930 0.57 0.96
SCN5A rs2268755 0.805 0.2663 1.344 0.00341 rs12053903 1.23 0.88 1.57 1 3 1014 QTGEN 91,477 0.597 0.79
KCNH2 rs2968854 1.632 0.416 2.848 0.00853 rs2968863 1.35 0.98 1.8 2 3 1015 QTSCD 14,697 0.55 0.74
The following abbreviations are used: GWAS, genome-wide association study, and LD, linkage disequilibrium.of the Q wave to the latest offset of the T wave, and the
heart-rate corrected QT interval (QTc interval) was calcu-
lated by the Bazett method with the 12SL program.12
The majority of genomic DNAs that were genotyped on
the Affymetrix Genome-Wide Human SNP array 5.0 were
isolated from peripheral blood that was drawn from
KARE participants. We sequentially discarded 38,364
markers with a Hardy-Weinberg equilibrium p value
< 106, 17,926 markers with genotype call rates below
95%, and 92,050 markers with a minor allele frequency
(MAF) < 0.01; we were left with 352,228 SNPs for subse-
quent analysis. The genotyping quality-control protocol
is described in a previous report by Cho et al.10
Population stratification was assessed by multidimen-
sional scaling and principal-component analyses, which
demonstrated that the characteristics of the phase 1 KARE
participants were similar to those of the Japanese and
Chinese (HCB [Han Chinese in Beijing, China] and JPT
[Japanese in Tokyo, Japan]) components of HapMap.10The AmThe genomic inflation factor of the phase 1 participants
was 1.013.
Most association analyses were performed with PLINK
(version 1.07) and SAS (version 9.1). SNPs were tested
for association by linear regression with an additive
model (1 degree of freedom) after adjustments for age,
sex, systolic blood pressure, and recruitment area
(Figure S3). We combined KARE GWAS and replication-
study results by inverse-variance meta-analysis under the
assumption of fixed effects by using Cochran’s Q test to
assess between-study heterogeneity.13 All meta-analysis
calculations were implemented in METAL (see Web
Resources).
We performed an association analysis in the phase 1
study by using Bazett QTc intervals and a subsequent
meta-analysis by using inverse normal transformed (INT)
values of the QTc interval (INT QTc interval). The INT
method permits p values and the direction of the effect
to be combined independently of beta estimates, allowingFigure 1. Manhattan Plot of Genome-wide
Association Signals from Phase 1 Study
The log10(p) values are plotted against chromo-
somal base-pair positions. Pink labeling indicates
previously reported loci for the QT interval, and
green labeling indicates previously unreported
loci showing associations with the QT interval
in the phase 1 study and tested for replication.
The red line represents the genome-wide signifi-
cance level (p ¼ 5 3 108).
erican Journal of Human Genetics 91, 180–184, July 13, 2012 181
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182 The American Journal of Human Genetics 91, 180–184, July 13, 2for differences in QTc distribution between studies
(Figure S2). Genome-wide significance was inferred at
p < 5 3 108.
Genotyping of the 4,686 subjects in the Korean replica-
tion study was performed with the GoldenGate assay14
(Illumina). The accuracy of the GoldenGate assay was
tested by duplicate genotyping of 1%–2.5% of the samples
as quality control. All replicate SNPs showed concordance
rates in the duplicates of over 99% and genotype success
rates of over 98%. On the basis of these results, genotyping
errors could be disregarded for these SNPs in subsequent
association analyses.
Genotyping of the 2,687 subjects in the Japanese replica-
tion study (Millenium Genome Project) was performed
with the TaqMan assay. The genotype success rates of the
genotyped SNPs exceeded 98%. This project has been
detailed elsewhere.15,16
In phase 1, eight SNPs, which lie near genes that have
been linked to the QT interval (such genes are NOS1AP
[MIM 610141], KCNQ1 [MIM 192500], KCNH2 [MIM
613688], NDRG4 [MIM 604917], PLN [MIM 172405], and
SCN5A [MIM 603830]), had a p value < 0.01 (Table 1). Of
the lead SNPs (pairwise linkage-disequilibrium statistics
r2 < 0.2 and MAF > 0.05) that had not been reported, we
selected the seven most strongly associated with noninter-
genic SNPs (p < 104) and four additional SNPs near repli-
cation-related genes in 4,686 Koreans and 2,687 Japanese
(Figure 1 and Table S3).
Of the 11 SNPs that were examined in the phase 2
study, rs13017846, located approximately 18 kb upstream
of SLC8A1 (MIM 182305), correlated significantly with
the QTc interval in both replication analyses (Table 2).
In the meta-analysis of the phase 1 and 2 studies, we
observed a highly significant p value for rs13017846,
wherein the G allele was linked to shorter QTc intervals
(combined beta ¼ 0.08 by INT QTc interval; standard
error of the mean [SEM] ¼ 0.01; p ¼ 8.0 3 1014; Table 2
and Figure 2).
SLC8A1 (sodium/calcium exchanger 1 precursor) is
a strong candidate for the observed association. SLC8A1
extrudes calcium from cardiac myocytes during relaxation
and returns the myocardium to its resting state after exci-
tation.17 Targeted disruption of SLC8A1 causes heartbeat
defects—SLC8A1/ mouse embryos experience slow and
arrhythmic heart contractions.18
Notably, the MAF of rs13017846 varies widely between
ethnicities—0.053 in Europeans (HapMap CEU [Utah resi-
dents with ancestry from northern and western Europe
from the Centre d0E´tude du Polymorphisme Humain
collection] samples) versus 0.080 in Africans (HapMap
YRI [Yoruba in Ibadan, Nigeria] samples)—whereas a MAF
of 0.500 was reported in Asians (HapMap HCB and JPT
samples); this might explain why this locus was not iden-
tified in earlier studies in Europeans. The eight reported
SNPs that also showed a significant association in our
phase 1 study had similar effects between ethnicities;
when an overlap of 95% confidence intervals between012
Figure 2. Signal Plot for rs13017846
across an 800 kb Window
Association of individual SNPs in the
phase 1 study is plotted as log10(p)
against the chromosomal base-pair posi-
tions. The y axis on the right shows the
recombination rate estimated from the
HapMap CHB and JPT populations. All
p values are from the discovery phase.
The purple diamond represents the result
of the meta-analysis of the phase 1 and 2
studies.ethnicities was considered, their effect sizes were also
similar.
In general, the Bazett formula overcorrects QT intervals
at high heart rates and undercorrects them at low rates.19
Because the QT interval is heavily influenced by heart
rate, there is concern that the common variant of
SLC8A1 governs heart rate rather than repolarization.
Thus, we used several methods, including the Hodges,20
Fridericia,21 and Framingham22 formulas, to correct heart
rate (Table S4), which showed that our finding was robust
to various correction methods. In the phase 1 and phase 2
Korean replication studies, the correlation between the RR
interval and rs13017846 was insignificant.
Limitations of our study include the method by which
QT intervals were measured. Because a digital caliper was
not used, the measurements might have been inconsis-
tent, especially if U waves or nonspecific ST-T changes
were present. However, we excluded subjects whose
endpoints of T waves were unclear. Also, QT-interval cova-
riates, such as serum potassium and calcium levels, were
not taken into account because they were not uniformly
available across studies.
In summary, we report an association between
a common genetic variant in SLC8A1 and the electrocar-
diographic QT interval. This locus appears to be involved
in myocardial relaxation, and our findings provide insight
into the electrophysiological mechanisms of myocardial
repolarization. Further evaluation of these pathwaysmight
facilitate the discovery of genetic biomarkers and the
development of new strategies for the prevention of
sudden cardiac death in high-risk individuals.Supplemental Data
Supplemental data include four figures and four tables and can be
found with this article online at http://www.cell.com/AJHG/.The AmAcknowledgments
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